A. Tchoghandjian

发表

A2B5 Expression in Central Nervous System and Gliomas

D. Figarella-Branger, C. Colin, N. Baeza-Kallee, 2022, International journal of molecular sciences.

Glycolipids Recognized by A2B5 Antibody Promote Proliferation, Migration, and Clonogenicity in Glioblastoma Cells

D. Figarella-Branger, R. Berges, R. Appay, 2019, Cancers.

Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells

S. Fulda, K. Rajalingam, A. Tchoghandjian, 2013, Cell Death and Disease.

Effects of VEGF blockade on the dynamics of the inflammatory landscape in glioblastoma-bearing mice

G. Rougon, M. Malissen, S. Brustlein, 2019, Journal of Neuroinflammation.

Identification and characterization of a non-conventional CD45 negative perivascular macrophage population within the mouse brain.

R. Adams, Sandrine Sarrazin, M. Sieweke, 2021 .

Challenges in glioblastoma research: focus on the tumor microenvironment.

I. Fournier, F. Ducray, M. Sanson, 2022, Trends in cancer.

Deciphering the heterogeneity of the Lyve1+ perivascular macrophages in the mouse brain

S. A. van de Pavert, R. Adams, M. Sieweke, 2022, Nature Communications.

Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature.

D. Figarella-Branger, C. Colin, L. Ouafik, 2009, Brain : a journal of neurology.

Proscillaridin A exerts anti-tumor effects through GSK3β activation and alteration of microtubule dynamics in glioblastoma

D. Figarella-Branger, R. Berges, D. Braguer, 2018, Cell Death & Disease.

Molecular heterogeneity of glioblastomas: does location matter?

O. Chinot, D. Figarella-Branger, C. Colin, 2015, Oncotarget.

Cortical and Subventricular Zone Glioblastoma-Derived Stem-Like Cells Display Different Molecular Profiles and Differential In Vitro and In Vivo Properties

F. Ducray, D. Figarella-Branger, G. Rougon, 2012, Annals of Surgical Oncology.

[Glioblastomas: gliomagenesis, genetics, angiogenesis, and microenvironment].

D. Figarella-Branger, C. Colin, C. Bouvier, 2010, Neuro-Chirurgie.

Impairment of lysosomal integrity by B10, a glycosylated derivative of betulinic acid, leads to lysosomal cell death and converts autophagy into a detrimental process

S. Fulda, K. Debatin, P. Gonzalez, 2012, Cell Death and Differentiation.

Practical Review on Preclinical Human 3D Glioblastoma Models: Advances and Challenges for Clinical Translation

A. Tchoghandjian, A. Soubéran, 2020, Cancers.

A2B5 Cells from Human Glioblastoma have Cancer Stem Cell Properties

D. Figarella-Branger, M. Cayre, C. Colin, 2010, Brain pathology.

EB1-dependent long survival of glioblastoma-grafted mice with the oral tubulin-binder BAL101553 is associated with inhibition of tumor angiogenesis

H. Lane, A. Sergé, D. Figarella-Branger, 2020, Oncotarget.

Tau Regulates Glioblastoma Progression, 3D Cell Organization, Growth and Migration via the PI3K-AKT Axis

D. Figarella-Branger, H. Kovacic, G. Breuzard, 2021, Cancers.

The dual PI3K/mTOR inhibitor NVP‐BEZ235 and chloroquine synergize to trigger apoptosis via mitochondrial‐lysosomal cross‐talk

S. Fulda, C. Seitz, A. Tchoghandjian, 2013, International journal of cancer.

Proscillaridin A exerts anti-tumor effects through GSK3β activation and alteration of microtubule dynamics in glioblastoma

D. Figarella-Branger, R. Berges, D. Braguer, 2018, Cell Death & Disease.

Phenotypic dynamics of microglial and monocyte-derived cells in glioblastoma-bearing mice

D. Figarella-Branger, G. Rougon, H. Luche, 2016, Scientific Reports.

Alternative responses of primary tumor cells and glioblastoma cell lines to N,N-bis-(8-hydroxyquinoline-5-yl methyl)-benzyl substituted amines: cell death versus P53-independent senescence.

J. Kraus, F. Conti, A. Tchoghandjian, 2010, International journal of oncology.

Somatic gain-of-function HIF2A mutations in sporadic central nervous system hemangioblastomas

D. Figarella-Branger, K. Pacak, A. Barlier, 2016, Journal of Neuro-Oncology.

The Novel Tubulin-Binding Checkpoint Activator BAL101553 Inhibits EB1-Dependent Migration and Invasion and Promotes Differentiation of Glioblastoma Stem-like Cells

H. Lane, D. Figarella-Branger, R. Berges, 2016, Molecular Cancer Therapeutics.

Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway

O. Chinot, D. Figarella-Branger, E. Tabouret, 2015, Oncotarget.

Smac mimetic promotes glioblastoma cancer stem-like cell differentiation by activating NF-κB

S. Fulda, D. Figarella-Branger, S. Momma, 2014, Cell Death and Differentiation.

Hypoxia-associated factor expression in low-grade and anaplastic gliomas: a marker of poor outcome.

David Taieb, Philippe Metellus, D. Figarella-Branger, 2016, Oncotarget.

Inhibitor of apoptosis protein expression in glioblastomas and their in vitro and in vivo targeting by SMAC mimetic GDC-0152

D. Figarella-Branger, C. Colin, A. El-Battari, 2016, Cell Death and Disease.

Identification of RIP1 as a critical mediator of Smac mimetic-mediated sensitization of glioblastoma cells for Drozitumab-induced apoptosis

C. Calaminus, S. Fulda, B. Pichler, 2015, Cell Death and Disease.

Relevance of combinatorial profiles of intermediate filaments and transcription factors for glioma histogenesis

D. Figarella-Branger, C. Colin, C. Bouvier, 2007, Neuropathology and applied neurobiology.

Effects of VEGF blockade on the dynamics of the inflammatory landscape in glioblastoma-bearing mice

G. Rougon, M. Malissen, S. Brustlein, 2019, Journal of Neuroinflammation.

Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo

D. Figarella-Branger, M. Carré, C. Colin, 2014, Oncotarget.

Inhibitor of Apoptosis Proteins Determines Glioblastoma Stem‐Like Cell Fate in an Oxygen‐Dependent Manner

D. Figarella-Branger, G. Rougon, H. Kovacic, 2019, Stem cells.

Inhibitor of apoptosis proteins determine glioblastoma stem-like cells fate depending on oxygen level

D. Figarella-Branger, G. Rougon, H. Kovacic, 2018, bioRxiv.

Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma

N. André, D. Figarella-Branger, M. Carré, 2013, Acta neuropathologica communications.

Deciphering the Action of Neuraminidase in Glioblastoma Models

D. Figarella-Branger, R. Berges, C. Colin, 2023, International journal of molecular sciences.

[Glioblastomas: gliomagenesis, genetics, angiogenesis, and microenvironment].

C. Colin, N. Baeza, A. Tchoghandjian, 2010, Neuro-Chirurgie.

The dual PI3K/mTOR inhibitor NVP‐BEZ235 and chloroquine synergize to trigger apoptosis via mitochondrial‐lysosomal cross‐talk

S. Fulda, C. Seitz, A. Tchoghandjian, 2013, International journal of cancer.

Challenges in glioblastoma research: focus on the tumor microenvironment: (Trends in Cancer, 9:1 p:9-27, 2023).

I. Fournier, F. Ducray, M. Sanson, 2023, Trends in cancer.

Abstract 837: Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells.

K. Rajalingam, A. Tchoghandjian, I. Eckhardt, 2013 .